Safety and Efficacy of Ivermectin for the Prevention and Treatment of COVID-19: A Double-Blinded Randomized Placebo-Controlled Study

• Hoofdauteurs: Nasikarn Angkasekwinai (Auteur), Pinyo Rattanaumpawan (Auteur), Methee Chayakulkeeree (Auteur), Pakpoom Phoompoung (Auteur), Pornpan Koomanachai (Auteur), Sorawit Chantarasut (Auteur), Walaiporn Wangchinda (Auteur), Varalak Srinonprasert (Auteur), Visanu Thamlikitkul (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2022-06-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

The safety and efficacy of ivermectin for the prevention and treatment of COVID-19 are still controversial topics. From August to November 2021, we conducted a double-blinded, randomized controlled trial at Siriraj Hospital, Thailand. Eligible participants were adults ≥ 18 years with suspected COVID...